Facet browsing currently unavailable
Page 2 of 43789 results
Sort by: relevance publication year
Whole-body hybrid PET/MRI: ready for clinical use? JOURNAL ARTICLE published June 2011 in European Journal of Nuclear Medicine and Molecular Imaging |
Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT JOURNAL ARTICLE published April 2003 in European Journal of Nuclear Medicine and Molecular Imaging |
Combined PET/MRI: a new dimension in whole-body oncology imaging? JOURNAL ARTICLE published March 2009 in European Journal of Nuclear Medicine and Molecular Imaging |
Deep learning-assisted ultra-fast/low-dose whole-body PET/CT imaging JOURNAL ARTICLE published July 2021 in European Journal of Nuclear Medicine and Molecular Imaging Research funded by Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNRF 320030_176052) |
FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection: response to Lazzeri et al JOURNAL ARTICLE published September 2014 in European Journal of Nuclear Medicine and Molecular Imaging |
Reply to: FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging JOURNAL ARTICLE published July 2010 in European Journal of Nuclear Medicine and Molecular Imaging |
Limitations of PET for imaging lymphoma JOURNAL ARTICLE published June 2003 in European Journal of Nuclear Medicine and Molecular Imaging |
Clinical evaluation of 2D versus 3D whole-body PET image quality using a dedicated BGO PET scanner JOURNAL ARTICLE published September 2005 in European Journal of Nuclear Medicine and Molecular Imaging |
Response to the letter to the editor: Lassen et al. 3D PET/CT 82Rb PET myocardial blood flow quantification: comparison of half-dose and full-dose protocols JOURNAL ARTICLE published November 2020 in European Journal of Nuclear Medicine and Molecular Imaging |
Letter to the editor: Lassen et al. 3D PET/CT 82Rb PET myocardial blood flow quantification: comparison of half-dose and full-dose protocols JOURNAL ARTICLE published November 2020 in European Journal of Nuclear Medicine and Molecular Imaging |
PET in lymphoma: what are the oncologist's needs? JOURNAL ARTICLE published June 2003 in European Journal of Nuclear Medicine and Molecular Imaging |
Prospective evaluation of 68Ga-DOTANOC PET-CT in differentiated thyroid cancer patients with raised thyroglobulin and negative 131I-whole body scan: comparison with 18F-FDG PET-CT JOURNAL ARTICLE published July 2014 in European Journal of Nuclear Medicine and Molecular Imaging |
Letter to the editor concerning “Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor” JOURNAL ARTICLE published January 2024 in European Journal of Nuclear Medicine and Molecular Imaging |
FDG-PET in gynaecological cancers: recent observations JOURNAL ARTICLE published November 2008 in European Journal of Nuclear Medicine and Molecular Imaging |
Combined whole-body dynamic and static PET/CT with low-dose [18F]PSMA-1007 in prostate cancer patients JOURNAL ARTICLE published 30 January 2024 in European Journal of Nuclear Medicine and Molecular Imaging |
Deep-JASC: joint attenuation and scatter correction in whole-body 18F-FDG PET using a deep residual network JOURNAL ARTICLE published October 2020 in European Journal of Nuclear Medicine and Molecular Imaging Research funded by Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNRF 320030_176052) |
Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states JOURNAL ARTICLE published August 2006 in European Journal of Nuclear Medicine and Molecular Imaging |
Optimal CT Number Range for Adipose Tissue When Determining Lean Body Mass in Whole-Body F-18 FDG PET/CT Studies JOURNAL ARTICLE published December 2012 in Nuclear Medicine and Molecular Imaging |
Impact of body habitus on quantitative and qualitative image quality in whole-body FDG-PET JOURNAL ARTICLE published 1 January 2003 in European Journal of Nuclear Medicine and Molecular Imaging |
18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with 131I JOURNAL ARTICLE published December 2020 in European Journal of Nuclear Medicine and Molecular Imaging |